Skip to main content
Erschienen in: World Journal of Surgery 6/2018

28.12.2017 | Original Scientific Report

Impact of the Weekday of Surgery on Outcome in Gastric Cancer Patients who Underwent D2-Gastrectomy

verfasst von: Felix Berlth, K. Messerle, P. S. Plum, S.-H. Chon, J. von Ambüren, A. Hohn, M. Dübbers, C. J. Bruns, S. P. Mönig, E. Bollschweiler, A. H. Hölscher, H. Alakus

Erschienen in: World Journal of Surgery | Ausgabe 6/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

The impact of the weekday of surgery in major elective cases of the upper-GI has been discussed controversially. The objective of this study was to assess whether weekday of surgery influences outcome in patients undergoing D2-gastrectomy.

Materials and methods

Patients who underwent D2-gastrectomy for gastric adenocarcinoma between 1996 and 2016 were included. Weekday of surgery was recognized, and subgroups were analyzed regarding clinical and histopathological differences. Survival analysis was performed based on weekday of surgery, and early weekdays (Monday–Tuesday) were compared with late weekdays (Wednesday–Friday).

Results

In total, 460 patients, 71% male and 29% female, were included into analysis. The median age was 65 years. Distribution to each weekday was equal and ranged from 86 cases (Wednesday) to 96 cases (Tuesday). The pT, pN and M category and the rate of patients who underwent neoadjuvant treatment did not show significant differences (p = 0.641; p = 0.337; p = 0.752; p = 0.342, respectively). The subgroups did not differ regarding the number of dissected lymph nodes and rate of R-1/2 resections (p = 0.590; p = 0.241, respectively). Survival analysis showed a median survival of 43 months (95% CI 31–55 months), and there was no single weekday or a combination of weekdays (Mon/Tue vs Wed/Thu/Fri) with a significant favorable or worse outcome (p = 0.863; p = 0.30, respectively). The outcome did not differ regarding mortality within the first 90 days after surgery (p = 0.948).

Conclusions

The present study does not show any evidence for a significant impact of weekday of surgery on short- and long-term outcome of patients undergoing gastrectomy for gastric adenocarcinoma.
Literatur
1.
Zurück zum Zitat Torre LA, Bray F, Siegel RL et al (2015) Global cancer statistics, 2012. CA Cancer J Clin 65:87–108CrossRefPubMed Torre LA, Bray F, Siegel RL et al (2015) Global cancer statistics, 2012. CA Cancer J Clin 65:87–108CrossRefPubMed
2.
Zurück zum Zitat Al-Batran SE, Hofheinz RD, Pauligk C et al (2016) Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2/3 trial. Lancet Oncol 17:1697–1708CrossRefPubMed Al-Batran SE, Hofheinz RD, Pauligk C et al (2016) Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2/3 trial. Lancet Oncol 17:1697–1708CrossRefPubMed
3.
Zurück zum Zitat Cho H, Nakamura J, Asaumi Y et al (2015) Long-term survival outcomes of advanced gastric cancer patients who achieved a pathological complete response with neoadjuvant chemotherapy: a systematic review of the literature. Ann Surg Oncol 22:787–792CrossRefPubMed Cho H, Nakamura J, Asaumi Y et al (2015) Long-term survival outcomes of advanced gastric cancer patients who achieved a pathological complete response with neoadjuvant chemotherapy: a systematic review of the literature. Ann Surg Oncol 22:787–792CrossRefPubMed
4.
Zurück zum Zitat Tsuburaya A, Sakamoto J, Morita S et al (2005) A randomized phase III trial of post-operative adjuvant oral fluoropyrimidine versus sequential paclitaxel/oral fluoropyrimidine; and UFT versus S1 for T3/T4 gastric carcinoma: the Stomach Cancer Adjuvant Multi-institutional Trial Group (Samit) Trial. Jpn J Clin Oncol 35:672–675CrossRefPubMed Tsuburaya A, Sakamoto J, Morita S et al (2005) A randomized phase III trial of post-operative adjuvant oral fluoropyrimidine versus sequential paclitaxel/oral fluoropyrimidine; and UFT versus S1 for T3/T4 gastric carcinoma: the Stomach Cancer Adjuvant Multi-institutional Trial Group (Samit) Trial. Jpn J Clin Oncol 35:672–675CrossRefPubMed
5.
Zurück zum Zitat Tsuburaya A, Yoshida K, Kobayashi M et al (2014) Sequential paclitaxel followed by tegafur and uracil (UFT) or S-1 versus UFT or S-1 monotherapy as adjuvant chemotherapy for T4a/b gastric cancer (SAMIT): a phase 3 factorial randomised controlled trial. Lancet Oncol 15:886–893CrossRefPubMed Tsuburaya A, Yoshida K, Kobayashi M et al (2014) Sequential paclitaxel followed by tegafur and uracil (UFT) or S-1 versus UFT or S-1 monotherapy as adjuvant chemotherapy for T4a/b gastric cancer (SAMIT): a phase 3 factorial randomised controlled trial. Lancet Oncol 15:886–893CrossRefPubMed
6.
Zurück zum Zitat Degiuli M, Sasako M, Ponti A et al (2014) Randomized clinical trial comparing survival after D1 or D2 gastrectomy for gastric cancer. Br J Surg 101:23–31CrossRefPubMed Degiuli M, Sasako M, Ponti A et al (2014) Randomized clinical trial comparing survival after D1 or D2 gastrectomy for gastric cancer. Br J Surg 101:23–31CrossRefPubMed
7.
Zurück zum Zitat Memon MA, Subramanya MS, Khan S et al (2011) Meta-analysis of D1 versus D2 gastrectomy for gastric adenocarcinoma. Ann Surg 253:900–911CrossRefPubMed Memon MA, Subramanya MS, Khan S et al (2011) Meta-analysis of D1 versus D2 gastrectomy for gastric adenocarcinoma. Ann Surg 253:900–911CrossRefPubMed
8.
Zurück zum Zitat Mocellin S, McCulloch P, Kazi H et al (2015) Extent of lymph node dissection for adenocarcinoma of the stomach. The Cochrane database of systematic reviews; Cd001964 Mocellin S, McCulloch P, Kazi H et al (2015) Extent of lymph node dissection for adenocarcinoma of the stomach. The Cochrane database of systematic reviews; Cd001964
9.
Zurück zum Zitat Lee KG, Lee HJ, Yang JY et al (2014) Risk factors associated with complication following gastrectomy for gastric cancer: retrospective analysis of prospectively collected data based on the Clavien–Dindo system. J Gastrointest Surg 18:1269–1277CrossRefPubMed Lee KG, Lee HJ, Yang JY et al (2014) Risk factors associated with complication following gastrectomy for gastric cancer: retrospective analysis of prospectively collected data based on the Clavien–Dindo system. J Gastrointest Surg 18:1269–1277CrossRefPubMed
10.
Zurück zum Zitat Nakagawa M, Kojima K, Inokuchi M et al (2016) Identification of frequency, severity and risk factors of complications after open gastrectomy: retrospective analysis of prospectively collected database using the Clavien–Dindo classification. J Med Dent Sci 63:53–59PubMed Nakagawa M, Kojima K, Inokuchi M et al (2016) Identification of frequency, severity and risk factors of complications after open gastrectomy: retrospective analysis of prospectively collected database using the Clavien–Dindo classification. J Med Dent Sci 63:53–59PubMed
11.
Zurück zum Zitat Lagergren J, Mattsson F, Lagergren P (2016) Weekday of esophageal cancer surgery and its relation to prognosis. Ann Surg 263:1133–1137CrossRefPubMed Lagergren J, Mattsson F, Lagergren P (2016) Weekday of esophageal cancer surgery and its relation to prognosis. Ann Surg 263:1133–1137CrossRefPubMed
12.
Zurück zum Zitat Zare MM, Itani KM, Schifftner TL et al (2007) Mortality after nonemergent major surgery performed on Friday versus Monday through Wednesday. Ann Surg 246:866–874CrossRefPubMed Zare MM, Itani KM, Schifftner TL et al (2007) Mortality after nonemergent major surgery performed on Friday versus Monday through Wednesday. Ann Surg 246:866–874CrossRefPubMed
13.
Zurück zum Zitat Visser E, van Rossum PS, Verhoeven RH et al (2016) Impact of weekday of esophagectomy on short-term and long-term oncological outcomes: a nationwide population-based cohort study in the Netherlands. Ann Surg 266:76–81CrossRef Visser E, van Rossum PS, Verhoeven RH et al (2016) Impact of weekday of esophagectomy on short-term and long-term oncological outcomes: a nationwide population-based cohort study in the Netherlands. Ann Surg 266:76–81CrossRef
14.
Zurück zum Zitat Meyer HJ, Holscher AH, Lordick F et al (2012) Current S3 guidelines on surgical treatment of gastric carcinoma. Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen 83:31–37CrossRefPubMed Meyer HJ, Holscher AH, Lordick F et al (2012) Current S3 guidelines on surgical treatment of gastric carcinoma. Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen 83:31–37CrossRefPubMed
15.
Zurück zum Zitat Bowman FTCF, Hruban RH, Lauwers GY, Carneiro F, Graham DY (2010) Classification of tumours of the digestive system. IARC, Lyon (in press) Bowman FTCF, Hruban RH, Lauwers GY, Carneiro F, Graham DY (2010) Classification of tumours of the digestive system. IARC, Lyon (in press)
16.
Zurück zum Zitat Tokunaga M, Hiki N, Fukunaga T et al (2009) Effect of individual fat areas on early surgical outcomes after open gastrectomy for gastric cancer. Br J Surg 96:496–500CrossRefPubMed Tokunaga M, Hiki N, Fukunaga T et al (2009) Effect of individual fat areas on early surgical outcomes after open gastrectomy for gastric cancer. Br J Surg 96:496–500CrossRefPubMed
17.
Zurück zum Zitat Wong J, Rahman S, Saeed N et al (2014) Effect of body mass index in patients undergoing resection for gastric cancer: a single center US experience. J Gastrointest Surg 18:505–511CrossRefPubMed Wong J, Rahman S, Saeed N et al (2014) Effect of body mass index in patients undergoing resection for gastric cancer: a single center US experience. J Gastrointest Surg 18:505–511CrossRefPubMed
18.
Zurück zum Zitat Yoshikawa K, Shimada M, Kurita N et al (2011) Visceral fat area is superior to body mass index as a predictive factor for risk with laparoscopy-assisted gastrectomy for gastric cancer. Surg Endosc 25:3825–3830CrossRefPubMed Yoshikawa K, Shimada M, Kurita N et al (2011) Visceral fat area is superior to body mass index as a predictive factor for risk with laparoscopy-assisted gastrectomy for gastric cancer. Surg Endosc 25:3825–3830CrossRefPubMed
19.
Zurück zum Zitat Glance LG, Osler T, Li Y et al (2016) Outcomes are worse in US patients undergoing surgery on weekends compared with weekdays. Med Care 54:608–615CrossRefPubMed Glance LG, Osler T, Li Y et al (2016) Outcomes are worse in US patients undergoing surgery on weekends compared with weekdays. Med Care 54:608–615CrossRefPubMed
20.
Zurück zum Zitat Mohan S, Foley K, Chiles MC et al (2016) The weekend effect alters the procurement and discard rates of deceased donor kidneys in the United States. Kidney Int 90:157–163CrossRefPubMedPubMedCentral Mohan S, Foley K, Chiles MC et al (2016) The weekend effect alters the procurement and discard rates of deceased donor kidneys in the United States. Kidney Int 90:157–163CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Romain B, Grass F, Addor V et al (2016) Impact of weekday surgery on application of enhanced recovery pathway: a retrospective cohort study. BMJ Open 6:e011067CrossRefPubMedPubMedCentral Romain B, Grass F, Addor V et al (2016) Impact of weekday surgery on application of enhanced recovery pathway: a retrospective cohort study. BMJ Open 6:e011067CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Li Y, Yu W, Dai W et al (2016) Can the weekday of surgery influence the prognosis of colorectal cancer patients? A retrospective study based on a single-center of large sample. Zhonghua wei chang wai ke za zhi = Chin J Gastrointest Surg 19:1129–1132 Li Y, Yu W, Dai W et al (2016) Can the weekday of surgery influence the prognosis of colorectal cancer patients? A retrospective study based on a single-center of large sample. Zhonghua wei chang wai ke za zhi = Chin J Gastrointest Surg 19:1129–1132
Metadaten
Titel
Impact of the Weekday of Surgery on Outcome in Gastric Cancer Patients who Underwent D2-Gastrectomy
verfasst von
Felix Berlth
K. Messerle
P. S. Plum
S.-H. Chon
J. von Ambüren
A. Hohn
M. Dübbers
C. J. Bruns
S. P. Mönig
E. Bollschweiler
A. H. Hölscher
H. Alakus
Publikationsdatum
28.12.2017
Verlag
Springer International Publishing
Erschienen in
World Journal of Surgery / Ausgabe 6/2018
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-017-4398-4

Weitere Artikel der Ausgabe 6/2018

World Journal of Surgery 6/2018 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.